rolipram has been researched along with Dyskinesia, Medication-Induced in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol treatment significantly increased dyskinetic movements and striatal dopamine D2 receptor density compared with controls." | 1.29 | Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol. ( Fukui, S; Hashimoto, K; Inada, T; Iyo, M; Sasaki, H, 1995) |
| "This haloperidol treatment also induced a significantly increase in the frequency of involuntary chewing movements and tongue protrusions, which are considered as a model of tardive dyskinesia." | 1.29 | Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats. ( Fukui, S; Hashimoto, K; Inada, T; Iyo, M; Kitao, Y; Maeda, Y; Sasaki, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanes, SJ | 1 |
| Tokarczyk, J | 1 |
| Siegel, SJ | 1 |
| Bilker, W | 1 |
| Abel, T | 1 |
| Kelly, MP | 1 |
| Sasaki, H | 2 |
| Hashimoto, K | 2 |
| Inada, T | 3 |
| Fukui, S | 2 |
| Iyo, M | 2 |
| Maeda, Y | 1 |
| Kitao, Y | 1 |
| Yagi, G | 1 |
1 review available for rolipram and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Current topics in tardive dyskinesia in Japan.
Topics: Antipsychotic Agents; Central Nervous System Agents; Ceruletide; Clinical Trials as Topic; Cross-Cul | 1995 |
3 other studies available for rolipram and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acoustic Stimulation; Animals; Antipsychotic Agents; Behavior, | 2007 |
Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antipsychotic Agents; Dep | 1995 |
Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Dyskinesia, Drug-Induced; Haloperidol; M | 1995 |